Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice

被引:0
|
作者
Pamela J. Skinner
Cynthia A. Vierra-Green
Effat Emamian
Huda Y. Zoghbi
Harry T. Orr
机构
[1] University of Minnesota,Department of Laboratory Medicine and Pathology
[2] University of Minnesota,Department of Genetics, Cell and Developmental Biology
[3] University of Minnesota,Institute of Human Genetics
[4] Baylor College of Medicine,Departments of Pediatrics, and Molecular and Human Genetics, Howard Hughes Medical Institute
来源
NeuroMolecular Medicine | 2002年 / 1卷
关键词
ataxia; polyglutamine; SCA1; disease progression;
D O I
暂无
中图分类号
学科分类号
摘要
Spinocerebellar ataxia type 1 (SCA1) belongs to a family of polyglutamine induced neurodegenerative disorders. Transgenic mice that overexpress a mutant allele of the SCA1 gene develop a progressive ataxia and Purkinje cell pathology. In this report, the pathological importance of a segment of ataxin-1 previously shown to be important for protein-protein interactions was examined. While the absence of a 122 amino acid segment from the protein-protein interaction region of ataxin-1 did not effect the initiation of disease, its absence substantially suppressed the progression of disease in SCA1 transgenic mice. Thus, these data suggest that this region of ataxin-1 has a role in disease progression. Furthermore, these results provide evidence that ataxin-1-induced disease initiation and disease progression involve distinct molecular events.
引用
收藏
页码:33 / 42
页数:9
相关论文
共 50 条
  • [1] Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice
    Skinner, PJ
    Vierra-Green, CA
    Emamian, E
    Zoghbi, HY
    Orr, HT
    NEUROMOLECULAR MEDICINE, 2002, 1 (01) : 33 - 42
  • [2] Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice
    Emamian, ES
    Kaytor, MD
    Duvick, LA
    Zu, T
    Tousey, SK
    Zoghbi, HY
    Clark, HB
    Orr, HT
    NEURON, 2003, 38 (03) : 375 - 387
  • [3] Ataxin-1 nuclear localization and aggregation:: Role in polyglutamine-induced disease in SCA1 transgenic mice
    Klement, IA
    Skinner, PJ
    Kaytor, MD
    Yi, H
    Hersch, SM
    Clark, HB
    Zoghbi, HY
    Orr, HT
    CELL, 1998, 95 (01) : 41 - 53
  • [4] Proteasome function is inhibited by polyglutamine-expanded ataxin-1, the SCA1 gene product
    Park, Y
    Hong, S
    Kim, SJ
    Kang, S
    MOLECULES AND CELLS, 2005, 19 (01) : 23 - 30
  • [5] SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in Purkinje cells of SCA1 transgenic mice
    Kang, S.
    Hong, S.
    ARCHIVES ITALIENNES DE BIOLOGIE, 2010, 148 (04): : 351 - 363
  • [6] Depletion of ROR-alpha by mutant ataxin-1 mediates Purkinje cell pathology in SCA1 transgenic mice
    Clark, H. Brent
    Serra, Heliane
    Duvick, Lisa
    Zu, Tao
    Carlson, Kerri
    Stevens, Sam
    Jorgensen, Nathan
    Zoghbi, Huda Y.
    Orr, Harrry T.
    BRAIN PATHOLOGY, 2006, 16 : S164 - S164
  • [7] Identification of a self-association region within the SCA1 gene product, ataxin-1
    Burright, EN
    Davidson, JD
    Duvick, LA
    Koshy, B
    Zoghbi, HY
    Orr, HT
    HUMAN MOLECULAR GENETICS, 1997, 6 (04) : 513 - 518
  • [8] Polyglutamine tract expansion: not enough for SCA1
    不详
    NEUROSCIENTIST, 2003, 9 (04): : 236 - 236
  • [9] Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1
    Cvetanovic, Marija
    Hu, Yuan-Shih
    Opal, Puneet
    CEREBELLUM, 2017, 16 (02): : 340 - 347
  • [10] Tissue transglutaminase crosslinks ataxin-1: Possible role in SCA1 pathogenesis
    D'Souza, D. R.
    Wei, J.
    Shao, Q.
    Hebert, M. D.
    Subramony, S. H.
    Vig, P. J. S.
    NEUROSCIENCE LETTERS, 2006, 409 (01) : 5 - 9